SEC Form 3 · accession 0001437749-18-022822
WINDTREE THERAPEUTICS INC /DE/ · WINT
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owners
KPCB China Holdings II, Ltd.
10% Owner
KPCB China Associates II, L.P.
10% Owner
KPCB China Fund II, L.P.
10% Owner
Ivy Blue Holdings Ltd
10% Owner
Period of report
Dec 21, 2018
Accepted (ET)
Dec 31, 2018 · 4:34 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000946486
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1 | holding | — | — | — | 4,336,790 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1The securities of the Issuer reported in this Form 3 are directly held by Ivy Blue Holdings Limited. KPCB China Fund II, L.P. is the 100% owner of Ivy Blue Holdings Limited. KPCB China Associates II, L.P. is the general partner of KPCB China Fund II, L.P. KPCB China Holdings II, Ltd. is the general partner of KPCB China Associates II, L.P. The directors of KPCB China Holdings II, Ltd. are Brook Byers, Wen Hsieh, James Huang and Theodore Schlein. By virtue of these relationships, Brook Byers, Wen Hsieh, James Huang and Theodore Schlein may be deemed to indirectly beneficially own the securities held by Ivy Blue Holdings Limited, however each disclaims beneficial ownership of such securities, except to the extent of his pecuniary interest therein.